New study cautions use of drugs to block 'niacin flush'
Niacin, or vitamin B3, is the one approved drug that elevates "good" cholesterol (high density lipoprotein, HDL) while depressing "bad" cholesterol (low density lipoprotein , LDL), and has thereby attracted much attention ...
Medical research
Apr 09, 2012 |
4 / 5 (4) |
0
|
Benefits of statin therapy may extend beyond lowering lipids
People with high cholesterol are at risk of heart attack and stroke because atherosclerotic plaques within their arteries can rupture triggering the formation of a blood clot called an occlusive thrombus that ...
Medical research
Jan 04, 2012 |
3 / 5 (1) |
0
|
Psoriasis is associated with impaired HDL function
Collaborative research from Perelman School of Medicine at the University of Pennsylvania has shown that psoriasis patients have an increased risk of heart attack, stroke and cardiovascular death, especially if the psoriasis ...
Medical research
Nov 16, 2011 |
5 / 5 (1) |
0
Novel therapeutic target identified to decrease triglycerides and increase 'good' cholesterol
Researchers at NYU Langone Medical Center today announce findings published in the October 20 issue of Nature that show for the first time the inhibition of both microRNA-33a and microRNA-33b (miR-33a/b) with chemically modifi ...
Medical research
Oct 20, 2011 |
4 / 5 (1) |
0
|
NIH stops clinical trial on combination cholesterol treatment
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health has stopped a clinical trial studying a blood lipid treatment 18 months earlier than planned. The trial found that adding high dose, ...
Medications
May 26, 2011 |
not rated yet |
1
FDA panel to weigh revoking key use of Abbott drug
(AP) -- A panel of advisers to the Food and Drug Administration will consider this week whether to revoke a key indication from Abbott's blockbuster cholesterol drug Trilipix.
Medications
May 17, 2011 |
not rated yet |
0
- Pages: 1 2
